Clinical Trials List
Protocol NumberFAPI_2022/07/06 V3
Not yet recruiting
2022-01-01 - 2024-12-31
Phase II
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Cheng-Ta Yang Division of Hematology & Oncology
- Tzu-Pei Su Division of Nuclear Medicine
- 吳青陽 Division of Thoracic Surgery
- Ping-Chih Hsu Division of Hematology & Oncology
- Chih-Hsi Kuo Division of Hematology & Oncology
- 枋岳甫 Division of Infectious Disease
- Shih-Hong Li Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
103 participants
-
Global
0 participants
